miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Increasing data shows miR-29a is a key regulator of oncogenicprocesses. It is significantly down-regulated in some kind ofhuman tumors and possibly functionally linked to cellularproliferation, survival and migration. However, the mechanismremains unclear. In this study, we report miR-29a is significantlyunder-expressed in gastric cancer compared to the healthydonor. The microvessel density is negatively related to miR-29aexpression in gastric cancer tissues. The ectopic expression ofmiR-29a significantly inhibits proliferation and invasion of gastriccancer cells. Furthermore, western blot combined with theluciferase reporter assays demonstrate that vascular endothelialgrowth factor A (VEGF-A) is direct target of miR-29a. This is thefirst time miR-29a was found to suppress the tumor microvesseldensity in gastric cancer by targeting VEGF-A. Taken together,these results suggest that miR-29a is a tumor suppressor in gastriccancer. Restoration of miR-29a in gastric cancer may be apromising therapeutic approach.
Abstract
Increasing data shows miR-29a is a key regulator of oncogenicprocesses. It is significantly down-regulated in some kind ofhuman tumors and possibly functionally linked to cellularproliferation, survival and migration. However, the mechanismremains unclear. In this study, we report miR-29a is significantlyunder-expressed in gastric cancer compared to the healthydonor. The microvessel density is negatively related to miR-29aexpression in gastric cancer tissues. The ectopic expression ofmiR-29a significantly inhibits proliferation and invasion of gastriccancer cells. Furthermore, western blot combined with theluciferase reporter assays demonstrate that vascular endothelialgrowth factor A (VEGF-A) is direct target of miR-29a. This is thefirst time miR-29a was found to suppress the tumor microvesseldensity in gastric cancer by targeting VEGF-A. Taken together,these results suggest that miR-29a is a tumor suppressor in gastriccancer. Restoration of miR-29a in gastric cancer may be apromising therapeutic approach.
참고문헌 (38)
- Kloosterman, W. P., "The diverse functions of microRNAs in animal development and disease", Dev. Cell, 11, pp.441~450 (2006)
- Esquela-Kerscher, A., "Oncomirs - microRNAs with a role in cancer", Nat. Rev. Cancer, 6, pp.259~269 (2006)
- Lewis, B. P., "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets", Cell, 120, pp.15~20 (2005)
- Wicha, M. S., "Stemming a tumor with a little miR", Nat. Med, 17, pp.162~164 (2011)
- Calin, G. A., "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc. Natl. Acad. Sci. U. S. A, 101, pp.2999~3004 (2004)
- Zhu, S., "MicroRNA-21 targets tumor suppressor genes in invasion and metastasis", Cell Res, 18, pp.350~359 (2008)
- Hiyoshi, Y., "MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma", Clin. Cancer Res, 15, pp.1915~1922 (2009)
- Huang, L., "MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3", Int. J. Cancer, 128, pp.1758~1769 (2011)
- Lo, W. L., "MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells", J. Pathol, 223, pp.482~495 (2011)
- Li, N., "miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells", Cancer Lett, 275, pp.44~53 (2009)
- Ward, B. P., "MicroRNAs in chronic lymphocytic leukemia", Exp. Mol. Pathol, 90, pp.173~178 (2011)
- Calin, G. A., "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc. Natl. Acad. Sci. U. S. A, 101, pp.2999~3004 (2004)
- Desjobert, C., "MiR-29a downregulation in ALK-positive anaplastic large-cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression", Blood, 117, pp.6627~6637 (2011)
- Grimson, A., "MicroRNA targeting specificity in mammals: determinants beyond seed pairing", Mol. Cell, 27, pp.91~105 (2007)
- Maragkakis, M., "Accurate microRNA target prediction correlates with protein repression levels", BMC Bioinformatics, 10, pp.295~ (2009)
- Maragkakis, M., "DIANA-microT web server: elucidating microRNA functions through target prediction", Nucleic Acids Res, 37, pp.273~276 (2009)
- Rehmsmeier, M., "Fast and effective prediction of microRNA", target duplexes, 2004, pp.10, 1507~1517
- Hirakawa, S., "VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis", J. Exp. Med, 201, pp.1089~1099 (2005)
- Nicoloso, M. S., "MicroRNAs--the micro steering wheel of tumour metastases", Nat. Rev. Cancer, 9, pp.293~302 (2009)
- Pandey, A. K., "miR-29a levels are elevated in the db", db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells, 2011, pp.332, 125~133
- Du B, Ma, L. M., "High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells", FEBS Lett, 584, pp.811~816 (2010)
- Kawashita, Y., "Circulating miR-29a levels in patients with scleroderma spectrum disorder", J. Dermatol. Sci, 61, pp.67~69 (2011)
- Hebert, S. S., "Loss of microRNA cluster miR-29a", b-1 in sporadic Alzheimer's disease correlates with increased BACE1, Proc. Natl. Acad. Sci. U. S .A, pp.2008, 105[DOI]
- Shioya, M., "Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3", Neuropathol. Appl. Neurobiol, 36, pp.320~330 (2010)
- Ahluwalia, J. K., "Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication", Retrovirology, 5, pp.117~ (2008)
- Bandyopadhyay, S., "Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture", J. Infect. Dis, 203, pp.1753~1762 (2011)
- Li, J., "Roles of miR-29a in the antifibrotic effect of FXR in hepatic stellate cells", Mol. Pharmacol, 89, pp.191~200 (2011)
- Mulkeen, A. L., "Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells", Arch. Surg, 141, pp.367~374 (2006)
- Petit, A. M., "Neutralizing antibodies against epidermal growth factor and ErbB-2", neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors, 1997, pp.151, 1523~1530
- Des Guetz G, "Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature", Br. J. Cancer, 94, pp.1823~1832 (2006)
- Kolev, Y., "Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma", Ann. Surg. Oncol, 14, pp.2738~2747 (2007)
- Ugalde, A. P., "Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53", EMBO J, 30, pp.2219~2232 (2011)
- Cui, Y., "MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer", PLoS One, 6, pp.e25872~ (2011)
- Ghosh, R., "Transcriptional regulation of VEGF-A by the unfolded protein response pathway", PLoS One, 5, pp.e9575~ (2010)
- Livak, K. J, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, pp.402~408 (2001)
- Weidner, N., "Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma", J. Natl. Cancer Inst, 84, pp.1875~1887 (1992)
- Tie, J., "MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor", PLoS Genet, 6, pp.e1000879~ (2010)
- Zhu, S., "MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1)", J. Biol. Chem, 282, pp.14328~14336 (2007)
